American Healthcare REIT, Inc. (AHR) is a high-flying stock to consider, with a recent price target reduction by Truist to $52 from $53. The firm maintains a “Buy” rating and is neutral on REITs for 2026, noting improvements in fundamentals. Truist remains bullish on healthcare, industrial, strip retail, gaming, and lodging REITs, but cautious on mall and office sectors. UBS also maintains a “Buy” rating on AHR with a price target of $56. AHR is a real estate investment trust specializing in clinical healthcare real estate. While AHR shows promise, certain AI stocks may offer better upside potential.

Read more at Yahoo Finance: Truist Reduces PT on American Healthcare REIT (AHR) Stock